Find the latest pharmaceutical market place for APIs enquiry about Diosmectite on PharmaCompass.com.

india-flag Flag

Diosmectite (MOQ) API needed in India [ENA25156]

A company that focuses on manufacturing of OSDs, parenteral and semi-solids is looking for suppliers of Diosmectite (MOQ) API for commercial purposes. The suppliers must support this enquiry with CoA.

Reply

28 Jan 2026

Smectite API needed in Hong Kong [ENA25111]

A company that focuses on the manufacturing of various finished formulations is looking for suppliers of Smectite API for development purposes. The suppliers must support this enquiry with CoA.

Reply

21 Jan 2026

Diosmectite API needed in Malaysia [ENA24210]

A company that focuses on providing services including exclusive formulation development, product research and development, regulatory support, and laboratory testing is looking for suppliers of Diosmectite API for development purposes. The suppliers must support this enquiry with GMP & CoA.

Reply

04 Oct 2025

Diosmectite (100 kg) API needed in Spain [ENA19416]

A company specializing in the manufacture of various finished formulations in the fields of gynecology and fertility, also offering contract manufacturing services is looking for suppliers of Diosmectite (100 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.

Reply

25 Apr 2024

Kazakhstan Flag

EP/USP Diosmectite (10 kg) API needed in Kazakhastan [ENA09678]

A pharmaceutical manufacturing company that specializes in the formulation of oral liquid dosage forms is looking for suppliers of EP/USP Diosmectite (10 kg) API for development and commercial purposes. The suppliers must support this enquiry with GMP and DMF.

Reply

08 Feb 2021

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.